Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

New Vircell COVID-19 spike quantitative VirClia® IgG monotest

Products are for professional/laboratory use only.  We are happy to announce the launch of the new VirClia® monotest to detect and quantify IgG antibodies against SARS-CoV-2 Spike in human serum or plasma, with strong correlation to neutralizing antibodies.


  • SARS-CoV-2 Spike protein antigen.
  • Quantitative assay in IU/ml for detection of IgG antibodies according to First WHO International Standard for anti-SARS-CoV-2 immunoglobulin NIBSC code: 20/136. Quantification range up to 1,000 IU/ml.
  • Excellent clinical sensitivity and specificity.
  • Strong correlation with neutralization assay
  • Compatible with the broadest infectious disease CLIA monotest panel in the market.

 


Find out more about the VirClia Lotus instrument

View Blog Post >

Find out more about VirClia IgG monotest

View Flyer >



Request a Quote

Request Quote

Recent Posts

Savyon – SeroFIA™ Chlamydia

The Gold Standard in Chlamydia Serodiagnostics with High Sensitivity and User-Friendly Design The SeroFIA™ Chlamydia product line by Savyon Diagnostics consists of specific Microimmunofluorescence assays (MIF)…

Read full article

Certest – Clostidium Difficile Rapid Test

Simplifying C. difficile Screening with Certest Rapid Tests Certest provides a diverse range of rapid tests designed for simple yet highly sensitive screening assays, enabling…

Read full article

Vircell – Aspergillus Galactomannan Ag VirClia® Monotest

Meet the Aspergillus Galactomannan Ag Virclia® Monotest The reliable result, just when you need it Rapid, on‑demand detection of invasive aspergillosis — no batching, no delays,…

Read full article